Drug therapy.
D000661:Amphetamine / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D002090:Butyrophenones / Q000627:therapeutic use; D004569:Electroencephalography; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D008094:Lithium / Q000627:therapeutic use; D008238:Lysergic Acid Diethylamide / Q000009:adverse effects; D001523:Mental Disorders / Q000188:drug therapy*; D010640:Phenothiazines / Q000009:adverse effects / Q000627:therapeutic use; D010919:Placebos; D011613:Psychotherapy; D012559:Schizophrenia / Q000188:drug therapy; D013566:Sympathomimetics / Q000627:therapeutic use; D014970:Xanthines / Q000627:therapeutic use
D000928:Antidepressive Agents; D002090:Butyrophenones; D006993:Hypnotics and Sedatives; D010640:Phenothiazines; D010919:Placebos; D013566:Sympathomimetics; D014970:Xanthines; D008238:Lysergic Acid Diethylamide; D008094:Lithium; D000661:Amphetamine